From: Antimicrobial stewardship in high-risk febrile neutropenia patients
Antibiotics | Intercept β0 [CI] | Period 1 | Period 2 | ||||
---|---|---|---|---|---|---|---|
Total | β1 [CI] | p-value | Total | β2 [CI] | p-value | ||
Aminoglycosides | + 10.69 [− 44.67; + 66.05] | 140 | + 5.77 [− 11.18; + 22.71] | 0.45 | 81 | − 5.09 [− 16.90; + 6.71] | 0.34 |
Glycopeptides | + 142.54 [+ 71.56; + 213.51] | 754 | + 2.47 [− 19.26; + 24.19] | 0.80 | 113 | − 17.34 [− 32.48;− 2.21] | 0.03 |
Carbapenems | + 112.95 [− 100.10; + 325.99] | 1187 | + 41.78 [− 23.42; + 106.99] | 0.17 | 331 | − 47.73 [− 93.15;− 2.31] | 0.04 |
Class 3 β-lactams | + 39.00 [+ 6.48; + 71.51] | 74 | − 8.35 [− 18.30; + 1.60] | 0.09 | 52 | + 4.89 [− 2.05; + 11.82] | 0.14 |
Class 4 β-lactams | + 203.79 [+ 18.64; + 388.94] | 1173 | + 12.32 [− 44.34; + 68.98] | 0.62 | 1642 | + 2.49 [− 36.98; + 41.96] | 0.89 |
Fluoroquinolones | + 43.18 [− 101.31; + 187.68] | 85 | − 7.32 [− 51.55; + 36.90] | 0.71 | 183 | + 5.99 [− 24.81; + 36.80] | 0.66 |
Daptomycine + Linezolide | + 6.43 [− 33.54; + 46.40] | 56 | + 2.01 [− 10.22; + 14.25] | 0.71 | 37 | − 2.05 [− 10.57; + 6.47] | 0.59 |
Cotrimoxazole | + 32.75 [− 20.97; + 86.46] | 286 | + 7.70 [− 8.74; + 24.14] | 0.30 | 86 | − 9.48 [− 20.93; + 1.97] | 0.09 |
All antibiotics | + 1692.82 [+ 1235.32; + 2150.33] | 6848 | − 105.66 [− 245.67; + 34.36] | 0.12 | 3473 | − 19.91 [− 117.45; + 77.63] | 0.64 |